Pharma Giants Invest Billions in U.S. Factories

Global drugmakers are investing billions in U.S. factories to circumvent Trump administrations 100% tariffs on branded medications. This policy is triggering a manufacturing surge, with companies like Pfizer, Eli Lilly, and Johnson & Johnson committing to significant investments. These moves are bolstering investor confidence and mitigating supply risks. Even heavyweights like Roche, Novartis, and Sanofi are joining in, creating thousands of jobs in biotech and therapies. This tariff push is reshaping global pharma chains, ensuring more American-made drugs and steady supplies. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/b97909fb48a44acd